🇺🇸 FDA
Patent

US 11530240

Catheter injectable cyclic peptide pro-gelators for myocardial tissue engineering

granted A61KA61K38/00A61K38/10

Quick answer

US patent 11530240 (Catheter injectable cyclic peptide pro-gelators for myocardial tissue engineering) held by The Regents of the University of California expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/00, A61K38/10, A61K45/06, A61K9/0019